Advanced Glycation End Products, Oxidation Products, and Incident Cardiovascular Events in Patients With Type 2 Diabetes.

Raymond Q MigrinoAramesh SaremiScott HowellGideon BahnBarbora De CourtenHenry GinsbergPaul J BeisswengerPeter D Reavennull null

Published in: Diabetes care (2017)

Lower levels of MetSO and higher levels of select AGE are associated with increased incident CVD and may help account for the limited benefit of intensive glucose lowering in type 2 diabetes.

Keyphrases

cardiovascular events
cardiovascular disease
type diabetes
coronary artery disease
glycemic control
blood glucose
hydrogen peroxide
blood pressure
skeletal muscle